Rhea-AI Summary
Aspen Neuroscience (ASPE) priced its initial public offering at $15.00 per share, with all shares offered by the company. The offering comprises 9,375,000 common shares and is expected to generate approximately $140.6 million in gross proceeds before underwriting discounts, commissions and other offering expenses.
Underwriters have a 30-day option to purchase up to an additional 1,406,250 shares. Trading on the Nasdaq Global Select Market is expected to begin October 30, 2026. The offering is expected to close November 2, 2026, subject to customary closing conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags